Arcanobacterium haemolyticum is a Gram-positive bacterium that can cause infections in humans, especially adolescents and young adults. It is commonly associated with pharyngitis but can also cause other infections, such as skin and soft tissue infections, pneumonia, and bacteremia.
The epidemiology of A. haemolyticum infections needs to be better understood due to the rarity of the infections and the lack of surveillance programs. However, it is believed that A. haemolyticum infections are more common in adolescents and young adults, with a peak incidence in individuals aged 15-25 years. The infection is also more prevalent in males than females.
A. haemolyticum is a commensal organism in the oropharynx of humans, and it is believed that the infection is transmitted through respiratory droplets or close contact with infected individuals. Outbreaks of A. haemolyticum infections have been reported in institutional settings, such as schools and military barracks, suggesting that person-to-person transmission mode.
Scientific Classification:
Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Actinomycetales
Family: Actinomycetaceae
Genus: Arcanobacterium
Species: Arcanobacterium haemolyticum
Structure:
Arcanobacterium haemolyticum is a Gram-positive, non-motile, beta-hemolytic facultatively anaerobic bacterium.
It is a small bacillus-shaped pathogen that typically grows in chains or clusters.
The cell wall of A. haemolyticum contains peptidoglycan, which provides structural support to the cell, as well as teichoic acids and lipoteichoic acids. These surface molecules play a role in the bacterium’s interaction with its environment and can contribute to virulence.
haemolyticum also produces hemolysins, toxins that can damage red blood cells and contribute to the hemolytic activity of the bacterium. In addition, it produces proteases, which are enzymes that can degrade proteins and may contribute to the bacterium’s pathogenicity.
Like many other bacteria, A. haemolyticum contains a circular chromosome composed of DNA and plasmids that can contain additional genetic material, such as antibiotic-resistance genes.
There are several antigenic types of Arcanobacterium haemolyticum based on the surface antigens expressed by the bacterium. These antigens include:
Lipopolysaccharide (LPS): A. haemolyticum produces LPS, a complex molecule composed of lipids and sugars. LPS can vary between different strains of A. haemolyticum and contribute to differences in virulence.
Protein antigens: A. haemolyticum produces several protein antigens, including a 40-kDa surface protein, a 67-kDa surface protein, and a 100-kDa surface protein. These proteins can vary between different strains of A. haemolyticum and can be used to distinguish between different antigenic types.
Capsular polysaccharides: Some strains of A. haemolyticum produce capsular polysaccharides, which are complex sugars that can surround the bacterium and protect it from the immune system. The capsular polysaccharides can vary between different strains and contribute to differences in virulence.
Arcanobacterium haemolyticum is an opportunistic pathogen that can cause various infections in humans. While the exact mechanisms of pathogenesis are not fully understood, A. haemolyticum is thought to cause disease through several different mechanisms.
Invasion of host tissues: A. haemolyticum can invade host tissues and cause damage by producing phospholipase D and proteases. Phospholipase D can degrade phospholipids, which are major components of cell membranes, allowing the bacterium to penetrate and damage host cells. Proteases can also degrade host tissues and contribute to the bacterium’s ability to cause disease.
Hemolytic activity: A. haemolyticum produces hemolysins, toxins that can damage red blood cells and cause hemolysis. It can release hemoglobin and other cellular contents, contributing to the inflammatory response and tissue damage.
Immune evasion: A. haemolyticum produces a range of surface molecules, including capsular polysaccharides, that can help it evade the host immune system. The capsular polysaccharides can protect the bacterium from phagocytosis and other immune defenses, allowing it to persist and cause infection.
Biofilm formation: A. haemolyticum can form biofilms, which are communities of bacteria embedded in a matrix of extracellular polymeric substances. Biofilms can protect bacteria from antibiotics and the immune system, allowing them to persist and cause chronic infections.
Innate immune response: It includes physical and chemical barriers such as skin, mucous membranes, and antimicrobial proteins, as well as various immune cells such as neutrophils, macrophages, and dendritic cells.
These cells recognize and respond to A. haemolyticum through pattern recognition receptors (PRRs) on their surfaces, which detect pathogen-associated molecular patterns (PAMPs) on the bacteria. It triggers the release of inflammatory cytokines and chemokines, which recruit other immune cells to the site of infection and activate the adaptive immune response.
Adaptive immune response: It involves the activation of antigen-specific T and B lymphocytes. When A. haemolyticum enters the body, its antigens are presented to T lymphocytes by antigen-presenting cells (APCs) such as dendritic cells. It activates antigen-specific T cells, which then help to activate B cells. The B cells produce antibodies specific to the A. haemolyticum antigens, which can neutralize the bacteria and aid their clearance from the body. In addition, T cells can directly kill infected host cells and help to activate and coordinate the immune response.
A. haemolyticum is a common cause of pharyngitis, which is throat inflammation. Symptoms like sore throat, difficulty swallowing, and fever are seen.
A. haemolyticum can cause skin infections such as erysipelas, cellulitis, and abscesses. Symptoms may consist of pain, redness, swelling, and fever.
A. haemolyticum can cause bone infections, such as osteomyelitis, which is bone and bone marrow inflammation. Symptoms may include pain, swelling, and fever.
A. haemolyticum has been associated with pneumonia in rare cases. Symptoms may include cough, shortness of breath, chest pain, and fever.
A. haemolyticum can cause infective endocarditis, an infection of the heart’s inner lining. Symptoms may include fever, fatigue, weight loss, and heart murmur.
In more severe cases, A. haemolyticum can cause bacteremia, the presence of bacteria in the bloodstream. Symptoms may include fever, chills, fatigue, and sepsis.
Diagnosing Arcanobacterium haemolyticum infection involves a combination of clinical examination, laboratory tests, and imaging studies. Some of the standard diagnostic methods for A. haemolyticum include:
The culture of the organism is the gold standard for the diagnosis of A. haemolyticum infection. Blood, throat swab, or biopsy specimens can be collected for culture. A. haemolyticum grows best on blood agar plates and may show beta-hemolysis, complete lysis of red blood cells around the colonies.
Gram staining of clinical specimens can provide preliminary information about the morphology and arrangement of the bacteria. A. haemolyticum appears as Gram-positive, non-spore-forming rods, often arranged in clusters or short chains.
haemolyticum can be identified by various biochemical tests, including catalase and oxidase tests, and the identification of specific metabolic products. For example, A. haemolyticum produces pyruvate, acetoin, and acid from glucose but not from lactose or sucrose.
Polymerase chain reaction (PCR) analysis can be used to determine A. haemolyticum DNA in clinical specimens, providing a rapid and sensitive method for diagnosis.
Serological tests, such as enzyme-linked immunosorbent assay (ELISA) or Western blot, can detect antibodies produced by the body in response to A. haemolyticum infection. However, these tests are not frequently used in clinical practice due to the limited availability of specific antibodies.
Imaging studies, such as X-rays, CT scans, or ultrasounds, may identify the presence and extent of infections caused by A. haemolyticum, such as pneumonia, osteomyelitis, or endocarditis.
Regular hand washing with soap, especially before eating or handling food, after using the restroom, and after encountering potentially contaminated surfaces.
Avoid close contact with individuals with a confirmed or suspected A. haemolyticum infection, as the bacteria can be spread through respiratory secretions.
Avoid sneezing or coughing during meetups to prevent the spread of respiratory secretions.
Proper disinfection of surfaces and medical equipment can help prevent the spread of A. haemolyticum in healthcare settings.
Education and awareness of the symptoms and risk factors of A. haemolyticum infection can help individuals seek prompt medical attention and prevent the spread of the infection.
Use of Antibiotics:A. haemolyticum is generally susceptible to antibiotics such as penicillin, erythromycin, and clindamycin, and most patients respond well to treatment.
Arcanobacterium haemolyticum is a Gram-positive bacterium that can cause infections in humans, especially adolescents and young adults. It is commonly associated with pharyngitis but can also cause other infections, such as skin and soft tissue infections, pneumonia, and bacteremia.
The epidemiology of A. haemolyticum infections needs to be better understood due to the rarity of the infections and the lack of surveillance programs. However, it is believed that A. haemolyticum infections are more common in adolescents and young adults, with a peak incidence in individuals aged 15-25 years. The infection is also more prevalent in males than females.
A. haemolyticum is a commensal organism in the oropharynx of humans, and it is believed that the infection is transmitted through respiratory droplets or close contact with infected individuals. Outbreaks of A. haemolyticum infections have been reported in institutional settings, such as schools and military barracks, suggesting that person-to-person transmission mode.
Scientific Classification:
Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Actinomycetales
Family: Actinomycetaceae
Genus: Arcanobacterium
Species: Arcanobacterium haemolyticum
Structure:
Arcanobacterium haemolyticum is a Gram-positive, non-motile, beta-hemolytic facultatively anaerobic bacterium.
It is a small bacillus-shaped pathogen that typically grows in chains or clusters.
The cell wall of A. haemolyticum contains peptidoglycan, which provides structural support to the cell, as well as teichoic acids and lipoteichoic acids. These surface molecules play a role in the bacterium’s interaction with its environment and can contribute to virulence.
haemolyticum also produces hemolysins, toxins that can damage red blood cells and contribute to the hemolytic activity of the bacterium. In addition, it produces proteases, which are enzymes that can degrade proteins and may contribute to the bacterium’s pathogenicity.
Like many other bacteria, A. haemolyticum contains a circular chromosome composed of DNA and plasmids that can contain additional genetic material, such as antibiotic-resistance genes.
There are several antigenic types of Arcanobacterium haemolyticum based on the surface antigens expressed by the bacterium. These antigens include:
Lipopolysaccharide (LPS): A. haemolyticum produces LPS, a complex molecule composed of lipids and sugars. LPS can vary between different strains of A. haemolyticum and contribute to differences in virulence.
Protein antigens: A. haemolyticum produces several protein antigens, including a 40-kDa surface protein, a 67-kDa surface protein, and a 100-kDa surface protein. These proteins can vary between different strains of A. haemolyticum and can be used to distinguish between different antigenic types.
Capsular polysaccharides: Some strains of A. haemolyticum produce capsular polysaccharides, which are complex sugars that can surround the bacterium and protect it from the immune system. The capsular polysaccharides can vary between different strains and contribute to differences in virulence.
Arcanobacterium haemolyticum is an opportunistic pathogen that can cause various infections in humans. While the exact mechanisms of pathogenesis are not fully understood, A. haemolyticum is thought to cause disease through several different mechanisms.
Invasion of host tissues: A. haemolyticum can invade host tissues and cause damage by producing phospholipase D and proteases. Phospholipase D can degrade phospholipids, which are major components of cell membranes, allowing the bacterium to penetrate and damage host cells. Proteases can also degrade host tissues and contribute to the bacterium’s ability to cause disease.
Hemolytic activity: A. haemolyticum produces hemolysins, toxins that can damage red blood cells and cause hemolysis. It can release hemoglobin and other cellular contents, contributing to the inflammatory response and tissue damage.
Immune evasion: A. haemolyticum produces a range of surface molecules, including capsular polysaccharides, that can help it evade the host immune system. The capsular polysaccharides can protect the bacterium from phagocytosis and other immune defenses, allowing it to persist and cause infection.
Biofilm formation: A. haemolyticum can form biofilms, which are communities of bacteria embedded in a matrix of extracellular polymeric substances. Biofilms can protect bacteria from antibiotics and the immune system, allowing them to persist and cause chronic infections.
Innate immune response: It includes physical and chemical barriers such as skin, mucous membranes, and antimicrobial proteins, as well as various immune cells such as neutrophils, macrophages, and dendritic cells.
These cells recognize and respond to A. haemolyticum through pattern recognition receptors (PRRs) on their surfaces, which detect pathogen-associated molecular patterns (PAMPs) on the bacteria. It triggers the release of inflammatory cytokines and chemokines, which recruit other immune cells to the site of infection and activate the adaptive immune response.
Adaptive immune response: It involves the activation of antigen-specific T and B lymphocytes. When A. haemolyticum enters the body, its antigens are presented to T lymphocytes by antigen-presenting cells (APCs) such as dendritic cells. It activates antigen-specific T cells, which then help to activate B cells. The B cells produce antibodies specific to the A. haemolyticum antigens, which can neutralize the bacteria and aid their clearance from the body. In addition, T cells can directly kill infected host cells and help to activate and coordinate the immune response.
A. haemolyticum is a common cause of pharyngitis, which is throat inflammation. Symptoms like sore throat, difficulty swallowing, and fever are seen.
A. haemolyticum can cause skin infections such as erysipelas, cellulitis, and abscesses. Symptoms may consist of pain, redness, swelling, and fever.
A. haemolyticum can cause bone infections, such as osteomyelitis, which is bone and bone marrow inflammation. Symptoms may include pain, swelling, and fever.
A. haemolyticum has been associated with pneumonia in rare cases. Symptoms may include cough, shortness of breath, chest pain, and fever.
A. haemolyticum can cause infective endocarditis, an infection of the heart’s inner lining. Symptoms may include fever, fatigue, weight loss, and heart murmur.
In more severe cases, A. haemolyticum can cause bacteremia, the presence of bacteria in the bloodstream. Symptoms may include fever, chills, fatigue, and sepsis.
Diagnosing Arcanobacterium haemolyticum infection involves a combination of clinical examination, laboratory tests, and imaging studies. Some of the standard diagnostic methods for A. haemolyticum include:
The culture of the organism is the gold standard for the diagnosis of A. haemolyticum infection. Blood, throat swab, or biopsy specimens can be collected for culture. A. haemolyticum grows best on blood agar plates and may show beta-hemolysis, complete lysis of red blood cells around the colonies.
Gram staining of clinical specimens can provide preliminary information about the morphology and arrangement of the bacteria. A. haemolyticum appears as Gram-positive, non-spore-forming rods, often arranged in clusters or short chains.
haemolyticum can be identified by various biochemical tests, including catalase and oxidase tests, and the identification of specific metabolic products. For example, A. haemolyticum produces pyruvate, acetoin, and acid from glucose but not from lactose or sucrose.
Polymerase chain reaction (PCR) analysis can be used to determine A. haemolyticum DNA in clinical specimens, providing a rapid and sensitive method for diagnosis.
Serological tests, such as enzyme-linked immunosorbent assay (ELISA) or Western blot, can detect antibodies produced by the body in response to A. haemolyticum infection. However, these tests are not frequently used in clinical practice due to the limited availability of specific antibodies.
Imaging studies, such as X-rays, CT scans, or ultrasounds, may identify the presence and extent of infections caused by A. haemolyticum, such as pneumonia, osteomyelitis, or endocarditis.
Regular hand washing with soap, especially before eating or handling food, after using the restroom, and after encountering potentially contaminated surfaces.
Avoid close contact with individuals with a confirmed or suspected A. haemolyticum infection, as the bacteria can be spread through respiratory secretions.
Avoid sneezing or coughing during meetups to prevent the spread of respiratory secretions.
Proper disinfection of surfaces and medical equipment can help prevent the spread of A. haemolyticum in healthcare settings.
Education and awareness of the symptoms and risk factors of A. haemolyticum infection can help individuals seek prompt medical attention and prevent the spread of the infection.
Use of Antibiotics:A. haemolyticum is generally susceptible to antibiotics such as penicillin, erythromycin, and clindamycin, and most patients respond well to treatment.
Arcanobacterium haemolyticum is a Gram-positive bacterium that can cause infections in humans, especially adolescents and young adults. It is commonly associated with pharyngitis but can also cause other infections, such as skin and soft tissue infections, pneumonia, and bacteremia.
The epidemiology of A. haemolyticum infections needs to be better understood due to the rarity of the infections and the lack of surveillance programs. However, it is believed that A. haemolyticum infections are more common in adolescents and young adults, with a peak incidence in individuals aged 15-25 years. The infection is also more prevalent in males than females.
A. haemolyticum is a commensal organism in the oropharynx of humans, and it is believed that the infection is transmitted through respiratory droplets or close contact with infected individuals. Outbreaks of A. haemolyticum infections have been reported in institutional settings, such as schools and military barracks, suggesting that person-to-person transmission mode.
Structure and Classification
Scientific Classification:
Kingdom: Bacteria
Phylum: Actinobacteria
Class: Actinobacteria
Order: Actinomycetales
Family: Actinomycetaceae
Genus: Arcanobacterium
Species: Arcanobacterium haemolyticum
Structure:
Arcanobacterium haemolyticum is a Gram-positive, non-motile, beta-hemolytic facultatively anaerobic bacterium.
It is a small bacillus-shaped pathogen that typically grows in chains or clusters.
The cell wall of A. haemolyticum contains peptidoglycan, which provides structural support to the cell, as well as teichoic acids and lipoteichoic acids. These surface molecules play a role in the bacterium’s interaction with its environment and can contribute to virulence.
haemolyticum also produces hemolysins, toxins that can damage red blood cells and contribute to the hemolytic activity of the bacterium. In addition, it produces proteases, which are enzymes that can degrade proteins and may contribute to the bacterium’s pathogenicity.
Like many other bacteria, A. haemolyticum contains a circular chromosome composed of DNA and plasmids that can contain additional genetic material, such as antibiotic-resistance genes.
Antigenic Types
There are several antigenic types of Arcanobacterium haemolyticum based on the surface antigens expressed by the bacterium. These antigens include:
Lipopolysaccharide (LPS): A. haemolyticum produces LPS, a complex molecule composed of lipids and sugars. LPS can vary between different strains of A. haemolyticum and contribute to differences in virulence.
Protein antigens: A. haemolyticum produces several protein antigens, including a 40-kDa surface protein, a 67-kDa surface protein, and a 100-kDa surface protein. These proteins can vary between different strains of A. haemolyticum and can be used to distinguish between different antigenic types.
Capsular polysaccharides: Some strains of A. haemolyticum produce capsular polysaccharides, which are complex sugars that can surround the bacterium and protect it from the immune system. The capsular polysaccharides can vary between different strains and contribute to differences in virulence.
Pathogenesis
Arcanobacterium haemolyticum is an opportunistic pathogen that can cause various infections in humans. While the exact mechanisms of pathogenesis are not fully understood, A. haemolyticum is thought to cause disease through several different mechanisms.
Invasion of host tissues: A. haemolyticum can invade host tissues and cause damage by producing phospholipase D and proteases. Phospholipase D can degrade phospholipids, which are major components of cell membranes, allowing the bacterium to penetrate and damage host cells. Proteases can also degrade host tissues and contribute to the bacterium’s ability to cause disease.
Hemolytic activity: A. haemolyticum produces hemolysins, toxins that can damage red blood cells and cause hemolysis. It can release hemoglobin and other cellular contents, contributing to the inflammatory response and tissue damage.
Immune evasion: A. haemolyticum produces a range of surface molecules, including capsular polysaccharides, that can help it evade the host immune system. The capsular polysaccharides can protect the bacterium from phagocytosis and other immune defenses, allowing it to persist and cause infection.
Biofilm formation: A. haemolyticum can form biofilms, which are communities of bacteria embedded in a matrix of extracellular polymeric substances. Biofilms can protect bacteria from antibiotics and the immune system, allowing them to persist and cause chronic infections.
Host Defense
Innate immune response: It includes physical and chemical barriers such as skin, mucous membranes, and antimicrobial proteins, as well as various immune cells such as neutrophils, macrophages, and dendritic cells.
These cells recognize and respond to A. haemolyticum through pattern recognition receptors (PRRs) on their surfaces, which detect pathogen-associated molecular patterns (PAMPs) on the bacteria. It triggers the release of inflammatory cytokines and chemokines, which recruit other immune cells to the site of infection and activate the adaptive immune response.
Adaptive immune response: It involves the activation of antigen-specific T and B lymphocytes. When A. haemolyticum enters the body, its antigens are presented to T lymphocytes by antigen-presenting cells (APCs) such as dendritic cells. It activates antigen-specific T cells, which then help to activate B cells. The B cells produce antibodies specific to the A. haemolyticum antigens, which can neutralize the bacteria and aid their clearance from the body. In addition, T cells can directly kill infected host cells and help to activate and coordinate the immune response.
Clinical manifestations
A. haemolyticum is a common cause of pharyngitis, which is throat inflammation. Symptoms like sore throat, difficulty swallowing, and fever are seen.
A. haemolyticum can cause skin infections such as erysipelas, cellulitis, and abscesses. Symptoms may consist of pain, redness, swelling, and fever.
A. haemolyticum can cause bone infections, such as osteomyelitis, which is bone and bone marrow inflammation. Symptoms may include pain, swelling, and fever.
A. haemolyticum has been associated with pneumonia in rare cases. Symptoms may include cough, shortness of breath, chest pain, and fever.
A. haemolyticum can cause infective endocarditis, an infection of the heart’s inner lining. Symptoms may include fever, fatigue, weight loss, and heart murmur.
In more severe cases, A. haemolyticum can cause bacteremia, the presence of bacteria in the bloodstream. Symptoms may include fever, chills, fatigue, and sepsis.
Diagnosis
Diagnosing Arcanobacterium haemolyticum infection involves a combination of clinical examination, laboratory tests, and imaging studies. Some of the standard diagnostic methods for A. haemolyticum include:
The culture of the organism is the gold standard for the diagnosis of A. haemolyticum infection. Blood, throat swab, or biopsy specimens can be collected for culture. A. haemolyticum grows best on blood agar plates and may show beta-hemolysis, complete lysis of red blood cells around the colonies.
Gram staining of clinical specimens can provide preliminary information about the morphology and arrangement of the bacteria. A. haemolyticum appears as Gram-positive, non-spore-forming rods, often arranged in clusters or short chains.
haemolyticum can be identified by various biochemical tests, including catalase and oxidase tests, and the identification of specific metabolic products. For example, A. haemolyticum produces pyruvate, acetoin, and acid from glucose but not from lactose or sucrose.
Polymerase chain reaction (PCR) analysis can be used to determine A. haemolyticum DNA in clinical specimens, providing a rapid and sensitive method for diagnosis.
Serological tests, such as enzyme-linked immunosorbent assay (ELISA) or Western blot, can detect antibodies produced by the body in response to A. haemolyticum infection. However, these tests are not frequently used in clinical practice due to the limited availability of specific antibodies.
Imaging studies, such as X-rays, CT scans, or ultrasounds, may identify the presence and extent of infections caused by A. haemolyticum, such as pneumonia, osteomyelitis, or endocarditis.
Control
Regular hand washing with soap, especially before eating or handling food, after using the restroom, and after encountering potentially contaminated surfaces.
Avoid close contact with individuals with a confirmed or suspected A. haemolyticum infection, as the bacteria can be spread through respiratory secretions.
Avoid sneezing or coughing during meetups to prevent the spread of respiratory secretions.
Proper disinfection of surfaces and medical equipment can help prevent the spread of A. haemolyticum in healthcare settings.
Education and awareness of the symptoms and risk factors of A. haemolyticum infection can help individuals seek prompt medical attention and prevent the spread of the infection.
Use of Antibiotics:A. haemolyticum is generally susceptible to antibiotics such as penicillin, erythromycin, and clindamycin, and most patients respond well to treatment.
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
Digital Certificate PDF
On course completion, you will receive a full-sized presentation quality digital certificate.
medtigo Simulation
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
medtigo Points
medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
Community Forum post/reply = 5 points
*Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.
All Your Certificates in One Place
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.
